24 MAY 2021,
Roche India and Cipla have announced the first batch of Roche’s antibody cocktail drug is now available in India for the treatment of mild to moderate COVID-19 in patients, who are at high risk.
कौन सी है दुनिया की सबसे खतरनाक किताब ?
The cocktail drug (Casirivimab and Imdevimab), priced at 59,750 per dose, received emergency use authorisation (EUA) by the Central Drugs Standard Control Organisation (CDSCO) this month.
-NAV GILL
